Literature DB >> 7682513

Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds.

S Y Osei1, R S Ahima, R K Minkes, J P Weaver, M C Khosla, P J Kadowitz.   

Abstract

Regional vascular responses to angiotensin (Ang)-(1-7), a heptapeptide derivative of Ang II were investigated in the feline hindquarters and mesenteric vascular beds under conditions of controlled flow. In the mesenteric vascular bed, injections of Ang-(1-7) in doses of 1, 3 and 10 micrograms produced dose-dependent decreases in mesenteric perfusion pressure whereas at doses of 30 and 100 micrograms, increases were observed. In contrast, in the hindquarters circulation, low doses produced increases while high doses produced decreases in perfusion pressure. In both vascular beds the degree of vasoconstriction was weak, being less than 1% of that elicited by Ang II. The vasoconstrictor effect of Ang-(1-7) in both the mesenteric and hindquarters vascular bed was blocked by DuP 753 (1 mg/kg i.v.), an Ang receptor subtype 1 (AT1) antagonist. The vasodilator responses in both vascular beds were partially blocked by the nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (100 mg/kg i.v.) but were unaffected by the cyclooxygenase inhibitor, meclofenamate (2.5 mg/kg i.v.). The present results show that in the peripheral vascular bed of the cat, Ang-(1-7) causes vasodilation or modest vasoconstriction, depending on the dose and the regional vascular bed studied. The present data also suggest that the vasodilator effect of the peptide may be mediated in part by the release of endothelium-derived relaxing factor and the vasoconstrictor effect by activation of the AT1 receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682513     DOI: 10.1016/0014-2999(93)90703-k

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

1.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

Review 2.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

Review 3.  Optimal strategies for preventing progression of renal disease: should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together?

Authors:  R Komers; S Anderson
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

4.  Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation.

Authors:  G Valdés; A M Germain; J Corthorn; C Berrios; A C Foradori; C M Ferrario; K B Brosnihan
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

Review 5.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 6.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

7.  Intratubular Renin-Angiotensin System in Hypertension.

Authors:  Yuki Suzaki; Minolfa C Prieto-Carrasquero; Hiroyuki Kobori
Journal:  Curr Hypertens Rev       Date:  2006

8.  The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat.

Authors:  R Soares de Moura; A C Resende; A F Emiliano; T Tano; A C Mendes-Ribeiro; M L G Correia; L C R Marins de Carvalho
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

9.  Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor.

Authors:  I Pörsti; A T Bara; R Busse; M Hecker
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

Review 10.  Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies.

Authors:  Lauren Anton; K Bridget Brosnihan
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.